Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 142, Issue 1, Pages 77-+Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2021.05.026
Keywords
-
Categories
Funding
- National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health, USA [RO1AR063146, P30AR069589]
Ask authors/readers for more resources
The study highlights the crucial roles of HDAC1 and HDAC2 in maintaining proliferation and survival of adult epidermal and basal cell carcinoma progenitors. Deletion of these genes leads to various abnormalities and cell loss, which can be partially rescued by p16 and p53 deletion. Therapeutic efficacy of HDAC1/2 inhibition may depend on the mutational status of p53 and p16.
HDAC inhibitors show therapeutic promise for skin malignancies; however, the roles of specific HDACs in adult epidermal homeostasis and in disease are poorly understood. We find that homozygous epidermal codeletion of Hdac1 and Hdac2 in adult mouse epidermis causes reduced basal cell proliferation, apoptosis, inappropriate differentiation, and eventual loss of Hdac1/2-null keratinocytes. Hdac1/2-deficient epidermis displays elevated acetylated p53 and increased expression of the senescence gene p16. Loss of p53 partially restores basal proliferation, whereas p16 deletion promotes long-term survival of Hdac1/2-null keratinocytes. In activated GLI2-driven pre-basal cell carcinoma, Hdac1/2 deletion dramatically reduces proliferation and increases apoptosis, and knockout of either p53 or p16 partially rescues both proliferation and basal cell viability. Topical application of the HDAC inhibitor romidepsin to the normal epidermis or to GLI2 Delta N-driven lesions produces similar defects to those caused by genetic Hdac1/2 deletion, and these are partially rescued by loss of p16. These data reveal essential roles for HDAC1/2 in maintaining proliferation and survival of adult epidermal and basal cell carcinoma progenitors and suggest that the efficacy of therapeutic HDAC1/2 inhibition will depend in part on the mutational status of p53 and p16.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available